The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Fibroblasts Isolated from Normal Lungs and Those with Idiopathic Pulmonary Fibrosis Differ in Interleukin-6/gp130-Mediated Cell Signaling and Proliferation
Open accessAbstract
Interleukin (IL)-6 and IL-11 are elevated in a variety of lung conditions and may impact on repair mechanisms in chronic inflammatory disorders. However, the mechanisms by which these cytokines influence fibroblast proliferation in normal and disease states have not been previously addressed. We examined the effect of these cytokines on proliferation and cell-cycle kinetics of primary human lung fibroblasts obtained from normal patients and patients with idiopathic pulmonary fibrosis (IPF). IL-6 inhibited the proliferation of normal fibroblasts due to the sustained phosphorylation of STAT-3 and production of the cyclin-dependent kinase inhibitor p19(INK4D). In contrast IL-6 was mitogenic for IPF fibroblasts due to the sustained activation of MAPK, which in turn inhibited the production of p27(Kip1), allowing activation of cyclin D(1) and hyperphosphorylation of retinoblastoma protein. IL-11 was mitogenic for both normal and IPF fibroblasts. These results provide strong evidence for a fundamental abnormality in a cytokine-signaling pathway, as opposed to alterations in cytokine production, in the pathogenesis of IPF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 15 patients, there were three SAEs, but none related to the study drug per the principal investigator. There was no benefit in key secondary endpoints for efficacy: FVC, 6MWD, or modified Medical Research Dyspnea Scale (mMRC) (NCT02503657) [179].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [179]
Citations
Cites
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130 · cited 1×
“The actions of these cytokines are mediated through specific cell-surface receptors, which consist of a unique chain and the shared signal transducing subunit, gp130.(25,26) IL-6 has a variety of well-documented direct effects that are potentially relevant to pulmonary inflammation and fibrosis and levels of IL-6 are…”
BackgroundSelman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786 · cited 3×
“Fibroblasts within these foci assume a migratory, followed by a proliferative, and ultimately a profibrotic, myofibroblastic phenotype.(2,6) Myofibroblasts are characterized by the expression of markers of smooth muscle differentiation such as -smooth muscle actin ( -SMA) and are thought to be primarily responsible fo…”
Backgroundgp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461 · cited 3×
“IL-6 and IL-11 belong to a family of closely related pleiotropic cytokines that are produced by a variety of cells in response to inflammatory stimuli.(11) The actions of these cytokines are mediated through specific cell-surface receptors, which consist of a unique chain and the shared signal transducing subunit, gp1…”
BackgroundInterleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272 · cited 1×
“The actions of these cytokines are mediated through specific cell-surface receptors, which consist of a unique chain and the shared signal transducing subunit, gp130.(25,26) IL-6 has a variety of well-documented direct effects that are potentially relevant to pulmonary inflammation and fibrosis and levels of IL-6 are…”
BackgroundIdiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039 · cited 1×
“Idiopathic pulmonary fibrosis (IPF) is a primarily untreatable, progressive fibrotic lung disorder with 5-year survival ranging from 30 to 50%.(1,2) Morphologically, the disease is characterized by abnormal parenchymal tissue remodeling and re-epithelialization, increased collagen deposition, and angiogenesis.”
BackgroundNakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00734.x · Cited by 565
Zhang, K., Rekhter, M. D., Gordon, D., & Phan, S. H. (1994) · PubMed · Cited by 480
Kuhn, C., & McDonald, J. A. (1991) · PubMed · Cited by 407
Wilborn, J., Crofford, L. J., Burdick, M. D., Kunkel, S. L., Strieter, R. M., & Peters-Golden, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117866 · Cited by 392 · cited 1×
“Similarly, eicosanoids such as PGE2 have been shown to regulate fibroblast proliferation.(35,36) Wilborn and colleagues(35) reported that IPF-Fb have decreased expression of cyclooxygenase and PGE2 production compared to normal Fb, allowing unrestricted proliferation.”
Background
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
George, P. M., Wells, A. U., & Jenkins, R. G. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30225-3 · Cited by 1,085
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 548
Metadata
- Authors
- Moodley, Y. P., Scaffidi, A. K., Misso, N. L., Keerthisingam, C., McAnulty, R. J., Laurent, G. J., Mutsaers, S. E., Thompson, P. J., & Knight, D. A.
- Affiliations
- The University of Western Australia (AU)
- The Royal Free Hospital (GB)
- Corresponding author
- Knight, Darryl A.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 163
- Issue
- 1
- Pages
- 345-354
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1868172
- OpenAlex
- W2009533207
- Cited by
- 165
- References
- 39
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 11 · 2022: 11 · 2021: 15 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 4 · 2016: 9 · 2015: 6 · 2014: 7 · 2013: 10 · 2012: 9
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- American Journal Of Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- idiopathic pulmonary fibrosis, lung fibroblasts, interleukin-6, interleukin-11, gp130 signaling, fibroblast proliferation, STAT3 phosphorylation, MAPK signaling, p27, cyclin D1, retinoblastoma protein, cell cycle regulation, cytokine signaling pathways
- MeSH terms
- Actins, Cell Division, Cells, Cultured, DNA-Binding Proteins, Enzyme Activation, Enzyme Inhibitors, Fibroblasts, Humans, Lung, Membrane Glycoproteins, Mitogens, Pulmonary Fibrosis, Signal Transduction, Trans-Activators, Antigens, CD, Interleukin-6, Oligonucleotides, Antisense, Interleukin-11, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Mitogen-Activated Protein Kinases, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p27, Cyclin-Dependent Kinase Inhibitor p19, STAT3 Transcription Factor, Cytokine Receptor gp130
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibroblasts Isolated from Normal Lungs and Those with Idiopathic Pulmonary Fibrosis Differ in Interleukin-6/gp130-Mediated Cell Signaling and Proliferation. https://app.cochat.ai/papers/10.1016/s0002-9440(10)63658-9
- The paper
- Moodley, Y. P., Scaffidi, A. K., Misso, N. L., Keerthisingam, C., McAnulty, R. J., Laurent, G. J., Mutsaers, S. E., Thompson, P. J., & Knight, D. A. (2003). Fibroblasts Isolated from Normal Lungs and Those with Idiopathic Pulmonary Fibrosis Differ in Interleukin-6/gp130-Mediated Cell Signaling and Proliferation. The American Journal of Pathology. https://doi.org/10.1016/s0002-9440(10)63658-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.